VIM and cancer: Hence, no wonder that most studies designated the significance of vimentin as a biomarker in cancers with clinical relevance in several types of cancers (Ben-Ze’ev and Raz, 1985; Hu et al., 2004; Jin et al., 2010; Li M. et al., 2010; Wei et al., 2008; Bogush et al., 2020) and the more in depth information can be found elsewhere (Satelli and Li, 2011; Zhao et al., 2013; Polioudaki et al., 2015; Mogre et al., 2022).